GOLDSTEIN DOV A MD 4
4 · BioAge Labs, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
GOLDSTEIN DOV A MD
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2026-03-01$4.38/sh+3,542$15,514→ 33,033 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1]2026-03-01−3,542→ 159,375 totalExercise: $4.38Exp: 2035-02-17→ Common Stock (3,542 underlying)
Footnotes (1)
- [F1]The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
Signature
/s/ Dov A. Goldstein|2026-03-03